Tyrosine kinase Abl1 (ABL1) can also regulate the fusion and release of coronavirus spike proteins [60,61], with several COVID-19 studies mentioning its potential therapeutic effects [62,63]. This evidence concerns the gene ABL1 and COVID-19.